Τίτλος:
Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
(1) Background: Following radical prostatectomy (RP), the absence of a demonstrable tumor on the specimen of a previously histologically proven malignancy is known as the pT0 stage. The aim of our present study is to perform a narrative review of current literature in order to determine the frequency and oncological outcomes in patients with pT0 disease. (2) Methods: A narrative review of all available literature was performed. (3) Results: The incidence of pT0 ranges between 0.07% and 1.3%. Predictors of the pT0 stage are only a single biopsy core with low-grade cancer, a cancer length not exceeding 2 mm and a high prostate volume. Biochemical recurrence ranges between 0 and 11%. (4) Conclusions: The absence of malignancy in the RP specimen despite a previous positive biopsy is a rare and unpredictable finding. Although the prognosis is considered to be excellent in most of the cases, a continued close follow-up is warranted. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Συγγραφείς:
Kalampokis, N.
Grivas, N.
Karavitakis, M.
Leotsakos, I.
Katafigiotis, I.
Moschovas, M.C.
van der Poel, H.
European Association of Urology (EAU) Young Academic Urologists (YAU) Robotic Urology Working Group
Περιοδικό:
Current Oncology
Λέξεις-κλειδιά:
Article; biochemical progression free survival; biochemical recurrence; cancer growth; cancer prognosis; cancer recurrence; cancer registry; cancer size; cancer staging; cancer surgery; castration resistant prostate cancer; controlled study; follow up; Gleason score; histology; hormonal therapy; human; human tissue; incidence; male; narrative; neoadjuvant therapy; nuclear magnetic resonance imaging; oncology; outcome assessment; progression free survival; prostate biopsy; prostate cancer; prostate carcinoma; prostate volume; prostatectomy; questionnaire; systematic review; transurethral resection; carcinoma; pathology; prostate; prostate tumor; prostatectomy, Carcinoma; Humans; Male; Neoplasm Staging; Prostate; Prostatectomy; Prostatic Neoplasms
DOI:
10.3390/curroncol29030111
